Percutaneous Transluminal Coronary Angioplasty - Global Opportunity Analysis and Industry Forecast, 2017-2023 - Product Image

Percutaneous Transluminal Coronary Angioplasty - Global Opportunity Analysis and Industry Forecast, 2017-2023

  • ID: 4403126
  • Report
  • Region: Global
  • 165 pages
  • Allied Analytics LLP
1 of 3
The global PTCA balloon catheters market was valued at $1,064 million in 2016, and is expected to reach $1,431 million by 2023, growing at a CAGR of 4.3% from 2017 to 2023. Percutaneous transluminal coronary angioplasty (PTCA) is a minimally-invasive procedure used to open blocked or narrowed coronary arteries. PTCA balloons are inflated inside a blocked coronary artery to open up the blockage and allow smooth blood flow.

Increase in geriatric population and changes in lifestyle of people, technological advancements, changes in FDA policy, and increase in prevalence of cardiovascular disorders are expected to drive the market growth. However, availability of alternative therapies and complications associated with PTCA balloon catheters restrain this growth.

The upsurge in demand for minimally invasive surgeries, rise in disposable incomes, and growth prospects in emerging economies of Asia-Pacific and LAMEA are expected to provide numerous opportunities for market growth during the forecast period.

The report segments the market based on product, delivery platform, compliance, balloon material, and region. Based on product, it is divided into normal balloon catheter, drug eluting balloon catheter, cutting balloon catheter, and scoring balloon catheter. Based on delivery platform it is bifurcated into over-the-wire (OTW) balloon catheter, and rapid exchange (RX)/monorail balloon catheter.

PTCA balloon catheters may either be semi-compliant or non-compliant. Materials such as polyolefin copolymer (POC), polyethylene (PE), and polyethylene terephthalate (PET) are used to manufacture PTCA balloons. By geography, the market is analyzed across North America (U.S., Canada, and Mexico), Europe (Germany, France, Italy, UK, Spain, and rest of Europe), Asia-Pacific (China, Japan, Australia, India, South Korea, and rest of Asia-Pacific), and LAMEA (Brazil, South Africa, Saudi Arabia, and rest of LAMEA).

KEY BENEFITS FOR STAKEHOLDERS

The study provides an in-depth analysis of the market with current trends and future estimations to elucidate the imminent investment pockets.
It offers a quantitative analysis from 2016 to 2023, which is expected to enable the stakeholders capitalize on prevailing market opportunities.
Product and material segmentation analysis helps understand the various types of devices and materials used to manufacture PTCA balloons.
Comprehensive analysis of all geographical regions is provided, which determines the prevailing opportunities.
Key players are profiled and their strategies are analyzed thoroughly, which helps understand competitive outlook of the global market.

KEY MARKET SEGMENTS

BY PRODUCT

Normal balloon catheter
Drug eluting balloon catheter
Cutting balloon catheter
Scoring balloon catheter

BY DELIVERY PLATFORM

Rapid Exchange (RX) / Monorail balloon catheter
Over-the-wire (OTW) balloon catheter

BY COMPLIANCE

Semi-Compliant
Non-Compliant

BY BALLOON MATERIAL

Polyolefin copolymer (POC)
Polyethylene (PE)
Polyethylene terephthalate (PET)

BY REGION

North America
U.S.
Canada
Mexico
Europe
Germany
France
UK
Italy
Spain
Rest of Europe
Asia-Pacific
Japan
China
India
Australia
South Korea
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Saudi Arabia
Rest of LAMEA

LIST OF KEY PLAYERS PROFILED IN THE REPORT

Abbott Laboratories
B. Braun Melsungen AG
BIOTRONIK SE & Co. KG
Boston Scientific Corporation
C. R. Bard, Inc.
Cardinal Health, Inc.
Medtronic plc
MicroPort Scientific Corporation
Terumo Corporation
THE SPECTRANETICS CORPORATION

LIST OF OTHER PLAYERS IN THE VALUE CHAIN (These players are not profiled in the report. The same will be included on request)

Lepu Medical Technology (Beijing) Co., Ltd.
Meril Life Sciences Pvt. Ltd.
COOK MEDICAL INC.
READ MORE
Note: Product cover images may vary from those shown
2 of 3
CHAPTER 1 INTRODUCTION

1.1. REPORT DESCRIPTION
1.2. KEY BENEFITS FOR STAKEHOLDERS
1.3. KEY MARKET SEGMENTS
1.4. RESEARCH METHODOLOGY

1.4.1. Secondary research
1.4.2. Primary research
1.4.3. Analyst tools and models

CHAPTER 2 EXECUTIVE SUMMARY

2.1. KEY FINDINGS OF THE STUDY
2.2. CXO PERSPECTIVE

CHAPTER 3 MARKET OVERVIEW

3.1. MARKET DEFINITION AND SCOPE
3.2. KEY FINDINGS

3.2.1. Top investment pockets
3.2.2. Top winning strategies

3.2.2.1. Competitive intelligence of companies and their strategies

3.3. MARKET SHARE ANALYSIS, 2016
3.4. MARKET DYNAMICS

3.4.1. Drivers

3.4.1.1. Increasing ageing population and changing lifestyle of people
3.4.1.2. Technological advancements
3.4.1.3. Changes in FDA policy
3.4.1.4. Constant rise in incidences of heart disease

3.4.2. Restraints

3.4.2.1. Availability of alternative therapies such as tissue transplantation, bypass surgery, and medicines
3.4.2.2. Complications associated with balloon catheters

3.4.3. Opportunities

3.4.3.1. Growth opportunities in emerging nations
3.4.3.2. Rise in demand for minimally-invasive surgeries

3.4.4. Impact analysis

3.5. CLINICAL TRIALS

CHAPTER 4 GLOBAL PTCA BALLOON CATHETERS MARKET, BY PRODUCT

4.1. OVERVIEW

4.1.1. Market size and forecast

4.2. NORMAL BALLOON CATHETERS

4.2.1. Key market trends
4.2.2. Growth factors and opportunities
4.2.3. Market size and forecast

4.3. DRUG ELUTING BALLOON CATHETER

4.3.1. Key market trends
4.3.2. Growth factors and opportunities
4.3.3. Market size and forecast

4.4. CUTTING BALLOON CATHETER

4.4.1. Key market trends
4.4.2. Growth factors and opportunities
4.4.3. Market size and forecast

4.5. SCORING BALLOON CATHETER

4.5.1. Key market trends
4.5.2. Growth factors and opportunities
4.5.3. Market size and forecast

CHAPTER 5 GLOBAL PTCA BALLOON CATHETERS MARKET, BY DELIVERY PLATFORM

5.1. OVERVIEW

5.1.1. Market size and forecast

5.2. OVER-THE-WIRE (OTW) BALLOON CATHETER

5.2.1. Market size and forecast

5.3. RAPID EXCHANGE(RX)/ MONORAIL BALLOON CATHETER

5.3.1. Market size and forecast

CHAPTER 6 GLOBAL PTCA BALLOON CATHETERS MARKET, BY COMPLIANCE

6.1. OVERVIEW

6.1.1. Market size and forecast

6.2. SEMI-COMPLIANT

6.2.1. Market size and forecast

6.3. NON-COMPLIANT

6.3.1. Market size and forecast

CHAPTER 7 GLOBAL PTCA BALLOON CATHETERS MARKET, BY BALLOON MATERIAL

7.1. OVERVIEW

7.1.1. Market size and forecast

7.2. POLYOLEFIN COPOLYMER (POC)

7.2.1. Market size and forecast

7.3. POLYETHYLENE (PE)

7.3.1. Market size and forecast

7.4. POLYETHYLENE TEREPHTHALATE (PET)

7.4.1. Market size and forecast

CHAPTER 8 PTCA BALLOON CATHETERS MARKET, BY REGION

8.1. OVERVIEW

8.1.1. Market size and forecast

8.2. NORTH AMERICA

8.2.1. Key market trends
8.2.2. Key growth factors and opportunities
8.2.3. Market size and forecast
8.2.4. U.S.
8.2.5. Canada
8.2.6. Mexico

8.3. EUROPE

8.3.1. Key market trends
8.3.2. Key growth factors and opportunities
8.3.3. Market size and forecast
8.3.4. Germany
8.3.5. France
8.3.6. UK
8.3.7. Italy
8.3.8. Spain
8.3.9. Rest of Europe

8.4. ASIA-PACIFIC

8.4.1. Key market trends
8.4.2. Key growth factors and opportunities
8.4.3. Market size and forecast
8.4.4. Japan
8.4.5. China
8.4.6. India
8.4.7. Australia
8.4.8. South Korea
8.4.9. Rest of Asia-Pacific

8.5. LAMEA

8.5.1. Key market trends
8.5.2. Key growth factors and opportunities
8.5.3. Market size and forecast
8.5.4. Brazil
8.5.5. South Africa
8.5.6. Saudi Arabia
8.5.7. Rest of LAMEA

CHAPTER 9 COMPANY PROFILES

9.1. ABBOTT LABORATORIES

9.1.1. Company overview
9.1.2. Operating business segments
9.1.3. Business performance
9.1.4. Key strategic moves and developments

9.2. B. BRAUN MELSUNGEN AG

9.2.1. Company overview
9.2.2. Operating business segments
9.2.3. Business performance
9.2.4. Key strategic moves and developments

9.3. BIOTRONIK SE & CO. KG

9.3.1. Company overview
9.3.2. Operating business segments
9.3.3. Key strategic moves and developments

9.4. BOSTON SCIENTIFIC CORPORATION

9.4.1. Company overview
9.4.2. Operating business segments
9.4.3. Business performance
9.4.4. Key strategic moves and developments

9.5. C. R. BARD, INC.

9.5.1. Company overview
9.5.2. Operating business segments
9.5.3. Business performance
9.5.4. Key strategic moves and developments

9.6. CARDINAL HEALTH, INC.

9.6.1. Company overview
9.6.2. Operating business segments
9.6.3. Business performance
9.6.4. Key strategic moves and developments

9.7. MEDTRONIC PLC

9.7.1. Company overview
9.7.2. Operating business segments
9.7.3. Business performance
9.7.4. Key strategic moves and developments

9.8. MICROPORT SCIENTIFIC CORPORATION

9.8.1. Company overview
9.8.2. Operating business segments
9.8.3. Business performance
9.8.4. Key strategic moves and developments

9.9. TERUMO CORPORATION

9.9.1. Company overview
9.9.2. Operating business segments
9.9.3. Business performance
9.9.4. Key strategic moves and developments

9.10. THE SPECTRANETICS CORPORATION

9.10.1. Company overview
9.10.2. Operating business segments
9.10.3. Business performance
9.10.4. Key strategic moves and developments
Note: Product cover images may vary from those shown
3 of 3

Loading
LOADING...

4 of 3
Note: Product cover images may vary from those shown
Adroll
adroll